go back

Perphenazine, Oral

Washington, DC rates for HCPCS Q0175

Perphenazine, 4 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $0 · 10th–90th $0$10%50%90th$0Professionalmedian $0 · 10th–90th $0$10%50%10th90th$0$0.5$1.0$2.0$5.0$10.0$20.0$50.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.48
Median
$0.48
Typical High
$0.48
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.39
Median
$0.48
Typical High
$0.48
CareFirst
Setting
Professional
Modifier
Global
Typical Low
$1.26
Median
$1.26
Typical High
$1.26
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.72
Median
$0.72
Typical High
$1.07
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.48
Median
$0.48
Typical High
$0.48
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$0.68
Median
$0.79
Typical High
$1.51
United
Setting
Facility
Modifier
Global
Typical Low
$0.47
Median
$0.47
Typical High
$0.47
United
Setting
Professional
Modifier
Global
Typical Low
$0.47
Median
$0.47
Typical High
$2.04